Axogen (AXGN) Equity Ratio (2010 - 2026)
Axogen's quarterly Equity Ratio came in at 0.85 in Q1 2026, up 57.44% year-on-year from 0.54 in Q1 2025, and up 45.5% quarter-over-quarter from 0.58 in Q4 2025.
Axogen has reported Equity Ratio for 17 years, with the latest figure at 0.85 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 57.44% year-over-year to 0.85; the trailing twelve-month figure through Mar 2026 stood at 0.85 (up 57.44% YoY), and the FY2025 full-year result was 0.58, up 13.96% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.85, up from 0.58 in the prior quarter.
- The five-year high for Equity Ratio was 0.85 in Q1 2026, with the low at 0.49 in Q4 2023.
- Average Equity Ratio over 5 years is 0.54, with a median of 0.52 recorded in 2024.
- Year-over-year, Equity Ratio fell 13.53% in 2022 and surged 57.44% in 2026.
- Tracing AXGN's Equity Ratio over 5 years: stood at 0.52 in 2022, then fell by 5.97% to 0.49 in 2023, then gained by 4.94% to 0.51 in 2024, then grew by 13.96% to 0.58 in 2025, then soared by 45.5% to 0.85 in 2026.
- The last three Equity Ratio figures came in at 0.85 (Q1 2026), 0.58 (Q4 2025), and 0.56 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | 0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.85 |
| Dec 31, 2025 | 0.58 |
| Sep 30, 2025 | 0.56 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.51 |
| Sep 30, 2024 | 0.52 |
| Jun 30, 2024 | 0.51 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.51 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.52 |
| Sep 30, 2022 | 0.52 |
| Jun 30, 2022 | 0.52 |
| Mar 31, 2022 | 0.52 |
| Dec 31, 2021 | 0.54 |
| Sep 30, 2021 | 0.55 |
| Jun 30, 2021 | 0.56 |
| Mar 31, 2021 | 0.61 |
| Dec 31, 2020 | 0.61 |
| Sep 30, 2020 | 0.63 |
| Mar 31, 2020 | 0.86 |
| Dec 31, 2019 | 0.85 |
| Sep 30, 2019 | 0.88 |
| Jun 30, 2019 | 0.88 |
| Mar 31, 2019 | 0.88 |
| Dec 31, 2018 | 0.92 |
| Sep 30, 2018 | 0.92 |
| Jun 30, 2018 | 0.94 |
| Mar 31, 2018 | 0.39 |
| Dec 31, 2017 | 0.43 |
| Sep 30, 2017 | 0.25 |
| Jun 30, 2017 | 0.26 |
| Mar 31, 2017 | 0.28 |
| Dec 31, 2016 | 0.32 |
| Sep 30, 2016 | 0.04 |
| Jun 30, 2016 | 0.09 |
| Mar 31, 2016 | 0.14 |
| Dec 31, 2015 | 0.22 |
| Sep 30, 2015 | 0.27 |
| Jun 30, 2015 | -0.14 |
| Mar 31, 2015 | -0.02 |
| Dec 31, 2014 | -0.69 |
| Sep 30, 2014 | -0.51 |
| Jun 30, 2014 | -0.32 |
| Mar 31, 2014 | -0.15 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | 0.14 |
| Jun 30, 2013 | -0.59 |
| Mar 31, 2013 | -0.34 |
| Dec 31, 2012 | -0.14 |
| Sep 30, 2012 | 0.12 |
| Jun 30, 2012 | 0.33 |
| Mar 31, 2012 | 0.39 |
| Dec 31, 2011 | 0.49 |
| Sep 30, 2011 | 0.55 |
| Jun 30, 2011 | 0.95 |
| Dec 31, 2010 | -4.23 |